Myocardial Infarction in Centenarians. Data from The Polish Registry of Acute Coronary Syndromes

• Main Authors: Jacek Piegza, Lech Poloński, Aneta Desperak, Andrzej Wester, Marianna Janion, Wiesław Mazurek, Wojciech Wojakowski, Adam Witkowski, Dariusz Dudek, Mariusz Gąsior
• Format: Article
• Language: English
• Published: MDPI AG 2020-10-01
• Series: Journal of Clinical Medicine
• Subjects: myocardial infarction; elderly; centenarians; percutaneous coronary intervention
• Online Access: https://www.mdpi.com/2077-0383/9/10/3377

Background: There are no data regarding the mortality rate, risks and benefits of particular reperfusion methods and pharmacological treatment complications in patients aged over 100 years with acute coronary syndromes. We sought to assess the treatment of myocardial infarction (MI) in patients older than 100 years and to determine prognostic factors for this group. Methods: Among the 716,566 patients recorded between 2003 and 2018 in the Polish Registry of Acute Coronary Syndromes, 104 patients aged ≥100 with MI were included. The patients were categorized into two groups: group 1 received conservative treatment (64 patients), and group 2 received invasive strategy (40 patients). Results: The frequencies of in-hospital mortality, MI and stroke were similar in both arms. No difference in the frequency of the combined endpoint (death, reinfarction, stroke) was noted. Invasive treatment was more advantageous for 12-month outcomes; 50 patients in group 1 (79%) and 23 patients in group 2 (57.50%) died (<i>p </i>= 0.017). The multivariate analysis identified the lower left ventricular ejection fraction (EF) (Hazard Ratio (HR) = 0.96; 95% Confidence Interval (CI): 0.94–0.99; <i>p </i>= 0.012), lack of coronary angiography (HR = 0.49; 95% CI: 0.24–0.99; <i>p </i>= 0.048) and cardiac arrest (HR = 4.61; 95% CI: 1.64–12.99; <i>p </i>= 0.0038) as predictors of 12-month mortality in this group. Conclusions: Invasive MI treatment may be beneficial for selected very old patients.